C18orf8 anticorps (FITC)

N° du produit ABIN1404026

L’anticorps Lapin Polyclonal anti-C18orf8 a été validé pour WB et IF (p). Il convient pour détecter C18orf8 dans des échantillons de Humain.

Aperçu rapide pour C18orf8 anticorps (FITC) (ABIN1404026)

Antigène: C18orf8 (Chromosome 18 Open Reading Frame 8 (C18orf8))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp C18orf8 est conjugé à/à la FITC

Application: Western Blotting (WB), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Détail du produit anti-C18orf8 anticorps (FITC)

Réactivité croisée: Humain

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human MIC1/C18orf8

Isotype: IgG

Information d'application

Indications d'application: IF(IHC-P) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur C18orf8

Antigène: C18orf8 (Chromosome 18 Open Reading Frame 8 (C18orf8))

Autre désignation: MIC1

Sujet:

Synonyms: C18orf8, Chromosome 18 open reading frame 8, Colon cancer associated protein Mic1, Colon cancer-associated protein Mic1, HsT2591, Mic-1, MIC1, MIC1_HUMAN, Uncharacterized protein C18orf8.

Background: MIC1 is a 657 amino acid protein that contains one MIC1 domain and is encoded by a gene which maps to human chromosome 18. Chromosome 18 houses over 300 protein-coding genes and contains nearly 76 million bases. There are a variety of diseases associated with defects in chromosome 18-localized genes, some of which include Trisomy 18 (also known as Edwards syndrome), Niemann-Pick disease, hereditary hemorrhagic telangiectasia, erythropoietic protoporphyria and follicular lymphomas.